AESTUS CAPITAL
AESTUS CAPITAL is a Seed, Series A, Series B, Series C+, buyout, secondary and debt fund in the US and Europe investing in AI and Healthcare.
- Stages
- Seed, Series A, Series B, Series C+, buyout, secondary, debt
- Sectors
- AI, Healthcare
- Invests in
- US-wide, Europe
- Actively investing
- Yes
- Founded
- 2019
Check size not disclosed
Thesis
Aestus Capital, founded in 2019 and based in Singapore, operates as a venture capital and private equity fund-of-funds manager with a focus on the alternative asset industry in the United States and Europe. The firm targets smaller and middle-market funds, as well as emerging, next-generation managers raising their first to third funds. Beyond fund investments, Aestus Capital actively engages in direct investments and co-investments alongside its fund managers, seeking exposure to high-performing companies in promising sectors within the US and Europe. They also opportunistically invest in secondary market transactions and liquid alternative funds to diversify returns. Their investment philosophy emphasizes being an experienced, long-term, and partnership-oriented investor. Aestus Capital Fund III, L.P. has announced an offering seeking up to $75.0 million. The firm is actively seeking new investments and is described as an 'unfunded company' by Tracxn, meaning it has not raised external funding for its own operations.
Common questions
Does AESTUS CAPITAL invest at the Seed stage?
Yes. AESTUS CAPITAL lists Seed, Series A, Series B, Series C+, buyout, secondary and debt among the stages it invests in.
Where does AESTUS CAPITAL invest?
AESTUS CAPITAL invests in the US and Europe.